10-K: FY2024 Annual Report
LifeMD, Inc. (LFMD) Q4 2024 Earnings Call Transcript Summary
8-K: LifeMD Reports Fourth Quarter 2024 Results
LifeMD Announces Integration With LillyDirect Pharmacy Provider to Offer Patients Streamlined Access to Branded Dual GLP-1/GIP Zepbound
LifeMD to Participate in the KeyBanc Capital Markets Healthcare Forum
LIFEMD INC PFD SER A 8.875% (LFMDP.US) will release its Earnings Reports after the market closes on March 10.
$LIFEMD INC PFD SER A 8.875%(LFMDP.US)$ will release its Earnings Reports after the market closes on March 10, and investors should pay attention. How was the previous performance? $LIFEMD INC PFD SER A 8.875%(LFMDP.US)$ had revenue of 53.3932 million USD and a net income of -5.4772 million USD in Q3 2024. In Q4 2023, the revenue was 44.8598 million USD, with a net income of -3.2222 million USD. The accounting standards used for the above data are US_GAAP. Bull.
LifeMD to Report Fourth Quarter 2024 Financial Results on March 10
LifeMD Announces Entry Into the Behavioral Health Market
LifeMD, Inc. 8.875% CUM PFD A Goes Ex Dividend Tomorrow
LIFEMD INC PFD SER A 8.875% To Go Ex-Dividend On January 3rd, 2025 With 0.55469 USD Dividend Per Share
December 25th (Eastern Time) - $LIFEMD INC PFD SER A 8.875%(LFMDP.US)$ is trading ex-dividend on January 3rd, 2025.Shareholders of record on January 3rd, 2025 will receive 0.55469 USD dividend per
LifeMD to Participate in the Mizuho Health Care Conference: Medical Device, Services, Technology and Distribution
10-Q: Q3 2024 Earnings Report
LifeMD Launches Affiliated Pharmacy to Drive End-to-End Patient Care and Operational Efficiency
LIFEMD INC PFD SER A 8.875% (LFMDP.US) will release its financial report after the market closes on November 7th.
$LIFEMD INC PFD SER A 8.875% (LFMDP.US) will release its financial report after the close on November 7th. How was the previous performance? $LIFEMD INC PFD SER A 8.875% (LFMDP.US) had a revenue of 50.661845 million US dollars and a net income of -6.837034 million US dollars in 2024/Q2. In 2023/Q3, the revenue was 38.613911 million US dollars, with a net income of -5.283147 million US dollars. The above data was used for the
LifeMD Launches TestoRx, a New Rex MD Direct-to-Consumer Testosterone Replacement Therapy Telehealth Offering
LIFEMD INC PFD SER A 8.875% To Go Ex-Dividend On October 4th, 2024 With 0.55469 USD Dividend Per Share
September 25th (Eastern Time) - $LIFEMD INC PFD SER A 8.875%(LFMDP.US)$ is trading ex-dividend on October 4th, 2024.Shareholders of record on October 4th, 2024 will receive 0.55469 USD dividend per
LifeMD to Participate in Three Investor Conferences During September
10-Q: Q2 2024 Earnings Report
LifeMD to Report Second Quarter 2024 Financial Results on August 7
LifeMD to Participate in Two Investor Conferences During August